Medtronic Receives Expanded FDA Approval for Verify Evaluation System

The FDA has granted PMA approval to Medtronic’s Verify Evaluation System for expanded use in basic evaluations of patient benefit from InterStim bladder and bowel control therapy.

The wireless touch-screen system allows for shorter — three to seven day — evaluations, accelerating the potential for long-term restoration of bladder or bowel function.

The Verify System and the long-term InterStim System provide mild electrical stimulation to the sacral nerves, which normalize communication between the bladder or bowel and the brain. — Michael Cipriano